Jorge Viera
Family · Clifton, NJNPI 1780038356
Payments from drug & device makers
Across 281 payments — averaging $16.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- AstraZeneca$948
- Braeburn Inc.$485
- AbbVie$208
- Indivior Inc.$187
- Exact Sciences$186
- plus $2K from 40 others
What the payments were for
- Food & beverage$4,701100%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,716 in reported general payments places this provider in the 90th percentile of 2,692 family providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 49 | $76,639 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 57 | $50,172 |
| FarxigaDapagliflozin Propanediol | 41 | $38,336 |
| OzempicSemaglutide | 30 | $35,371 |
| ProliaDenosumab | 17 | $28,690 |
| Diclofenac Sodium | 94 | $28,181 |
| EliquisApixaban | 19 | $27,663 |
| Nurtec OdtRimegepant Sulfate | 11 | $22,942 |
| VivitrolNaltrexone Microspheres | 13 | $21,397 |
| JanuviaSitagliptin Phosphate | 18 | $18,300 |
| XareltoRivaroxaban | 14 | $16,632 |
| VascepaIcosapent Ethyl | 27 | $13,573 |
| LinzessLinaclotide | 11 | $11,971 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 51 | $10,769 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $8,474 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $82 | $76,63949 claims |
| PfizerEliquis, Nurtec Odt | $117 | $50,60430 claims |
| GSKTrelegy Ellipta | $156 | $50,17257 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $948 | $46,81154 claims |
| Novo NordiskOzempic | $50 | $35,37130 claims |
| AmgenProlia | $100 | $28,69017 claims |
| Alkermes, Inc.Vivitrol | $80 | $21,39713 claims |
| MerckJanuvia | $66 | $18,30018 claims |
| AbbVieLinzess | $208 | $11,97111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,692 family providers in New Jersey.
Other family in Clifton
- Diane NaraineClifton$12K
- Jennifer DemaioMorristown$412K
- Kara TrlicaCranbury$186K
- Nicole BauerParamus$161K
- Angie GarciaWest New York$161K
- China BattistaWall Township$142K
- Nancy EisenbergerVoorhees$82K
- Jennifer AbitabiloGlen Ridge$54K
- Megan FiloramoMorristown$53K
- Shawn DenningToms River$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.